We aimed to investigate the effect of the fermentable carbohydrate inulin on weight maintenance, appetite and ectopic fat in subjects with prediabetes

Weight loss is associated with a decrease in PsO severity and improved quality of life (QoL).41,42 Weight loss greater than 5% is associated with a higher rate of minimum disease activity in patients who are obese or overweight and in treatment for PsO.43,44 The Mediterranean diet, which facilitates weight loss, reduces psoriatic lesions.45 Weight loss in patients with HS leads to a notable decrease in the number of lesions and, in some cases, disease remission.46 Dysfunctional adiposity has been associated with worse indices of CVR and Dermatology Quality of Life Index (DLQI) in patients with HS.47 The decrease in fatty tissue is associated with a decrease in molecular mechanisms that characterize the systemic inflammatory state.48 Diet and exercise are the first therapeutic step but these interventions are, however, often insufficient to achieve favorable outcomes in skin diseases, good response to treatment for these conditions, and a decrease in CVR

Compared to native glucagon and GLP-1, retatrutide shows lower potency at GLP-1 and glucagon receptors but higher potency at the GIP receptor
Semaglutide side effects usually last for the first 8 to 12 weeks of treatment
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate